Physician Profile
Based in Overland Park, KS, Carrie A. Mihordin, D.O. is listed in the NPI registry under rheumatology. According to Medicare claims data, Carrie cared for 775 Medicare patients across 153,138 services. The services billed most often include injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered), injection, tocilizumab, 1 mg, and injection, golimumab, 1 mg, for intravenous use. NPI 1548458672 identifies this record in the national registry.
Factual summary compiled by Guide.md from public records; not written by this provider.
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
5701 W 119TH ST STE 209, MID-AMERICA RHEUMATOLOGY CONSULTANTS
Overland Park, KS 66209
Within Rheumatology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Most searched conditions
Autoimmune
Bone
Bone Health
Connective Tissue
Genetic & Connective Tissue
Inflammatory
Joints
Nerve & Tendon
Skin & Soft Tissue
Skin & Vascular
Soft Tissue
Spine & Back
Vascular
Most searched procedures
Consultation
Consultations
Diagnostics & Injections
Education & Support
Imaging
Injections
Lab & Diagnostics
Lab Work
Medication Management
Pain Relief
Regenerative Medicine
153,138 services · 775 patients · 14 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Administration of chemotherapy into vein, 1 hour or less | Treatment | 96413 |
430 | More often than most peers in Rheumatology |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Treatment | 96401 |
392 | More often than most peers in Rheumatology |
| Administration of chemotherapy into vein, each additional hour | Treatment | 96415 |
137 | As often as other peers in Rheumatology |
| Injection of additional new drug or substance into vein | Treatment | 96375 |
33 | Less often than most peers in Rheumatology |
| Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Drug given | J0717 |
61,600 | More often than most peers in Rheumatology |
| Injection, tocilizumab, 1 mg | Drug given | J3262 |
53,800 | More often than most peers in Rheumatology |
| Injection, golimumab, 1 mg, for intravenous use | Drug given | J1602 |
19,843 | More often than most peers in Rheumatology |
| Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Drug given | J0129 |
8,025 | As often as other peers in Rheumatology |
| Injection, infliximab, excludes biosimilar, 10 mg | Drug given | J1745 |
5,950 | More often than most peers in Rheumatology |
| Injection, denosumab, 1 mg | Drug given | J0897 |
2,340 | Less often than most peers in Rheumatology |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Carrie A. Mihordin is a rheumatologist in Overland Park, KS. That is the designation recorded for this NPI in the federal registry, where it is listed as “Rheumatology”.
NPI registry
Carrie A. Mihordin is listed at 5701 W 119Th St Ste 209, Mid-America Rheumatology Consultants, Overland Park, KS 66209. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (913) 661-9980. Contact the office directly to confirm availability and scheduling.
NPI registry
Carrie A. Mihordin's National Provider Identifier is 1548458672. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Carrie A. Mihordin attended Other, graduating in 2004. This comes from the CMS National Downloadable File.
CMS public data
Carrie A. Mihordin has 22 years experience. Calculated from a graduation year of 2004, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, Carrie A. Mihordin provides treatments such as administration of chemotherapy into vein, 1 hour or less and administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by Carrie A. Mihordin. If this is you, claiming it is free.
Guide.md
Guide.md listings do not constitute medical advice or an endorsement.